E2F1 and prostate carcinoma: These distinct roles of E2F1 in the presence and the absence of SETD6 might explain previous findings pointing toward a conflicting role of E2F1 in prostate cancer [82], because in the light of our findings the effects of E2F1 on tumor progression depend on the SETD6 expression level of the cancer cell.